Literature DB >> 25825264

The mortality after surgery in primary lung cancer: results from the Danish Lung Cancer Registry.

Anders Green1, Jacob Hauge2, Maria Iachina3, Erik Jakobsen2.   

Abstract

OBJECTIVES: The study has been performed to investigate the mortality within the first year after resection in patients with primary lung cancer, together with associated prognostic factors including gender, age, tumour stage, comorbidity, alcohol abuse, type of surgery and post-surgical complications.
METHODS: All patients (n = 3363) from the nationwide Danish Lung Cancer Registry with first resection performed between 1 January 2007 and 31 December 2011 were analysed by Kaplan-Meier techniques and Cox-regression analysis concerning death within the first year after resection. Covariates included gender, age, comorbidity (Charlson comorbidity index), perioperative stage, type of resection, registered complications to surgery and alcohol abuse.
RESULTS: The cumulative deaths after 30 days, 90 days, 180 days and 360 days were 72 (2.1%), 154 (4.6%), 239 (7.1%) and 478 (14.2%), respectively. Low stage, female gender, young age, no comorbidity, no postoperative complications, no alcohol abuse and lobectomy as type of resection were favourable for survival.
CONCLUSIONS: Our results demonstrate that resection in primary lung cancer impacts mortality far beyond the initial 30 days after resection, which is conventionally considered a time window of relevance for the adverse outcome of surgery. Increased efforts should be made for optimizing the selection of patients suited for resection and for identifying patients at increased risk of death after resection. Furthermore, patients should be monitored more closely and more frequently, in particular those patients with high risk of death after resection.
© The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Lung cancer; Mortality; Resection; Risk factors

Mesh:

Year:  2015        PMID: 25825264     DOI: 10.1093/ejcts/ezv107

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  13 in total

1.  Improving lung cancer outcomes by improving the quality of surgical care.

Authors:  Raymond U Osarogiagbon; Thomas A D'Amico
Journal:  Transl Lung Cancer Res       Date:  2015-08

Review 2.  Modifiable risk factors for patients undergoing lung cancer surgery and their optimization: a review.

Authors:  Sylvain Gagné; Daniel I McIsaac
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

3.  Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment.

Authors:  Nika Guberina; Christoph Pöttgen; Martin Schuler; Maja Guberina; Georgios Stamatis; Till Plönes; Martin Metzenmacher; Dirk Theegarten; Thomas Gauler; Kaid Darwiche; Clemens Aigner; Wilfried E E Eberhardt; Martin Stuschke
Journal:  Radiat Oncol       Date:  2022-07-16       Impact factor: 4.309

4.  Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy.

Authors:  Thomas Iseli; Thierry Berghmans; Markus Glatzer; Achim Rittmeyer; Gilbert Massard; Valérie Durieux; Thomas Buchsbaum; Paul Martin Putora
Journal:  ERJ Open Res       Date:  2020-09-14

Review 5.  Measuring improvement in populations: implementing and evaluating successful change in lung cancer care.

Authors:  Xinhua Yu; Lisa M Klesges; Mathew P Smeltzer; Raymond U Osarogiagbon
Journal:  Transl Lung Cancer Res       Date:  2015-08

6.  Lessons learned from the Dutch Institute for Clinical Auditing: the Dutch model for quality assurance in lung cancer treatment.

Authors:  Naomi Beck; Fieke Hoeijmakers; Erwin M Wiegman; Hans J M Smit; Franz M Schramel; Willem H Steup; Ad F T M Verhagen; Wilhelmina H Schreurs; Michel W J M Wouters
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

Review 7.  The Danish National Database for Asthma.

Authors:  Vibeke Backer; Jesper Lykkegaard; Uffe Bodtger; Lone Agertoft; Lene Korshoej; Elvira Vaclavik Braüner
Journal:  Clin Epidemiol       Date:  2016-10-25       Impact factor: 4.790

8.  Chronological changes in lung cancer surgery in a single Japanese institution.

Authors:  Haruhiko Nakamura; Hiroki Sakai; Hiroyuki Kimura; Tomoyuki Miyazawa; Hideki Marushima; Hisashi Saji
Journal:  Onco Targets Ther       Date:  2017-03-06       Impact factor: 4.147

9.  Lung cancer resection and postoperative outcomes in COPD: A single-center experience.

Authors:  Emma Roy; Justine Rheault; Marc-Antoine Pigeon; Paula Antonia Ugalde; Christine Racine; Serge Simard; Gabriel Chouinard; Alexandre Lippens; Yves Lacasse; François Maltais
Journal:  Chron Respir Dis       Date:  2020 Jan-Dec       Impact factor: 2.444

10.  CDCP1 Expression Is a Potential Biomarker of Poor Prognosis in Resected Stage I Non-Small-Cell Lung Cancer.

Authors:  Yunha Nam; Chang-Min Choi; Young Soo Park; HyunA Jung; Hee Sang Hwang; Jae Cheol Lee; Jung Wook Lee; Jung Eun Lee; Jung Hee Kang; Byung Hun Jung; Wonjun Ji
Journal:  J Clin Med       Date:  2022-01-11       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.